This legislation requires direct-to-consumer advertisements for prescription drugs and biological products to include truthful and not misleading pricing information. Specifically, it mandates that the Secretary of Health and Human Services, acting through the Administrator of the Centers for Medicare & Medicaid Services (CMS), promulgate regulations within one year. These regulations will require television advertisements for drugs covered by Medicare or Medicaid to display the list price for a typical 30-day regimen or course of treatment. The Administrator will also determine whether these regulations should extend to other forms of advertising, the specific format for textual statements, and appropriate enforcement mechanisms. Additionally, CMS will consider if other price information should be included in these statements to further enhance transparency for consumers.